Featured News
Trending News
Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship
Allergan Aesthetics, the maker of onabotulinumtoxinA (Botox), has partnered with IFundWomen to ensure women entrepreneurs can apply for $25,000 funding, coaching and mentoring. The partnership, announced on International Women’s Day…
Clean Cells begins activities in the largest biopharmaceutical testing site in Europe
Clean Cells has launched analytical operations at its new €22 million ($24.1 million) plant based in Montaigu-Vendée. Clean Cells is part of the Clean Biologics Group, a supplier of quality…
GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare announced today at the European Congress of Radiology (ECR) in Vienna, Austria that it has completed the registration of Phase I subjects in the initial clinical development program…
Ascelia Pharma Meets Major Milestone With Patient Enrollment Completion For Orviglance Phase 3 Study, Sparkle
Ascelia Pharma AB, a biotech company focused on improving the lives of people with rare cancers, today announced the successful completion of patient enrollment in a clinical study. SPARKLE’s Phase…
Pfizer and Astellas announce positive topline results from Phase 3 EMBARK trial
Pfizer Inc. and Astellas Pharma Inc. published favorable baseline results from the Phase 3 EMBARK trial evaluating XTANDI® in men with hormone-responsive, non-metastatic prostate cancer at high risk for biochemical…
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
Tandem Diabetes Care, Inc., a leader in insulin delivery and diabetes technology, today announced that it has published the results of the Pediatric Artificial Pancreas (PEDAP) clinical trial in the…
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
Masimo has announced that updated guidelines published by the European Society of Anesthesiology and Intensive Care (ESAIC) highlight the value of continuous, non-invasive hemoglobin (Hb) monitoring to help patients Clinician…
Humana’s Economic Impact in Florida Totals $48 Billion
Health and wellness leader Humana Inc. will contribute a total of $48 billion to Florida’s overall economic impact in 2022. Additionally, Florida has more Humana employees and healthcare plan members…
